Citadel Advisors »

Artiva Biotherapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 798k 2.87
2025-06-30 $232k 154k 1.51
2025-03-31 $435k 145k 3.00
2024-12-31 $992k 104k 9.58
2024-09-30 $1.5M 104k 14.68

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Citadel Advisors
Franklin Resources
BlackRock
Millennium Management
Wellington Management Company
Vanguard Group
Bnp Paribas Arbitrage, Snc
Geode Capital Management
Alyeska Investment Group
Renaissance Technologies
State Street Corporation

View all funds holding Artiva Biotherapeutics